This month Dr. Karen Hiestand sits down with Dr. Nathalie Dowgray to talk about ethics in veterinary medicine. We're also featuring our monthly JFMS clinical spotlight interview in which Dr Kelly St Denis discusses the feline skin microbiome with Dr. Alison Diesel.To begin our episode, Nathalie is joined by Veterinary and Animal Ethics Lecturer andResearcher Dr Karen Heistand. They discuss the intricacies of balancing personal ethical views with those of caregivers or colleagues. Karen shares how she manages difficult ethical decisions and how we can improve things in practice.Kelly St Denis then sits down with Dr. Alison Diesel to discuss her JFMS clinical spotlight article The feline skin microbiome: interrelationship between health and disease as well as a wider discussion on Skin disease and dermatology.For further reading material please visit:https://journals.sagepub.com/doi/10.1177/1098612X231180231Host:Nathalie Dowgray, BVSc, MANZCVS, PgDip, MRCVS, PhD, Head of ISFM, International Society of Feline Medicine, International Cat Care, Tisbury, Wiltshire, UKSpeakers:Dr Karen Heistand, BVSc, BSc, MSc, MA, MRCVS, Lecturer and Researcher in Animal and Veterinary EthicsDr Kelly St Denis, MSc, DVM, DABVP (Feline), 2022 ISFM/AAFP Cat Friendly Veterinary Environment Guidelines Co-Chair, St Denis Veterinary Professional Corporation, Powassan, Ontario, CanadaDr Alison Diesel, DVM, DACVD, Veterinary Dermatologist and JFMS Spotlight AuthorFor ISFM members, the full recording of this discussion is available for you to listen to at portal.icatcare.org. To become an ISFM member, or find out more about our Cat Friendly schemes, visit icatcare.org
This month Dr. Karen Hiestand sits down with Dr. Nathalie Dowgray to talk about ethics in veterinary medicine. We're also featuring our monthly JFMS clinical spotlight interview in which Dr Kelly St Denis discusses the feline skin microbiome with Dr. Alison Diesel.
To begin our episode, Nathalie is joined by Veterinary and Animal Ethics Lecturer and
Researcher Dr Karen Heistand. They discuss the intricacies of balancing personal ethical views with those of caregivers or colleagues. Karen shares how she manages difficult ethical decisions and how we can improve things in practice.
Kelly St Denis then sits down with Dr. Alison Diesel to discuss her JFMS clinical spotlight article The feline skin microbiome: interrelationship between health and disease as well as a wider discussion on Skin disease and dermatology.
For further reading material please visit:
https://journals.sagepub.com/doi/10.1177/1098612X231180231
Host:
Nathalie Dowgray, BVSc, MANZCVS, PgDip, MRCVS, PhD, Head of ISFM, International Society of Feline Medicine, International Cat Care, Tisbury, Wiltshire, UK
Speakers:
Dr Karen Heistand, BVSc, BSc, MSc, MA, MRCVS, Lecturer and Researcher in Animal and Veterinary Ethics
Dr Kelly St Denis, MSc, DVM, DABVP (Feline), 2022 ISFM/AAFP Cat Friendly Veterinary Environment Guidelines Co-Chair, St Denis Veterinary Professional Corporation, Powassan, Ontario, Canada
Dr Alison Diesel, DVM, DACVD, Veterinary Dermatologist and JFMS Spotlight Author
For ISFM members, the full recording of this discussion is available for you to listen to at portal.icatcare.org. To become an ISFM member, or find out more about our Cat Friendly schemes, visit icatcare.org
Welcome to Chattering With ISFM, the official monthly podcast of the International Society of Feline Medicine, hosted by Nathalie Dowgray (Head of ISFM). Each month, we chatter about cats and cat-friendly practices with industry experts and contributors to The Journal of Feline Medicine and Surgery. Each episode contains highlights from our longer discussions and interviews, which are accessible to ISFM members at portal.icatcare.org. If you would like access to our full episodes, would like to become an ISFM member, or find out more about our Cat-Friendly schemes, visit icatcare.org.
Nathalie Dowgray: Hello and
welcome to the July 2023 episode
of chattering with ISFM. I'm
Nathalie Dowgray here, Head of
ISFM and the host of this
month's podcast. First up this
month we're in conversation with
Dr. Karen Hiestand. And we're
going to be talking about
veterinary ethics. We're also
featuring our monthly JFMS
clinical spotlight interview.
And this month, Dr. Kelly St
Denis is going to be talking to
Dr. Alison Diesel about the
feline skin microbiome. We hope
you enjoy this episode.
So how do we as veterinarians
make our ethical decisions?
There's a lot of factors that
are out of our control, both the
fun things about working with
cats, but also, there's a lot of
owner factors that implicate,
quite strongly sometimes, on the
clinical decision making that
we're making, which may in turn,
compromise our ethics sometimes.
Karen Hiestand: Usually. I
actually think that that
medicine for the entire vet team
is one of the most ethically
challenging roles that anyone
can have, it's far more
ethically challenging the
medical doctors and at the
essence, that's because we don't
have central tenant to what we
do. Doctors do. They're meant to
keep people alive and cause no
harm. And everyone agrees on
that, people don't agree about
animals. Everyone has different
opinions about animals in
general, they have different
opinions about different
species, they have different
opinions about different
individuals of a species in a
different context, that pet cat
matters more than that stray
cat. So everyone has a different
view as to what matters morally
when it comes to animals, which
makes our job to treat them
incredibly difficult. Because we
have to navigate all of those
different opinions all the time.
You as part of the veterinary
team will have your view about
the moral worth of individual
animals that you're seeing, but
the person bringing them to you,
who in our context owns them, is
going to have their own
individual view of the moral
worth of that individual. And
those two opinions may not gel
at all. So you might find
yourself at very opposing ends
of where you place the moral
value of the animal on the
table. And that can be
incredibly challenging to
navigate. When you are trying to
go one way they might be trying
to go another and it means we
can be incredibly compromised.
There's a huge literature on
something called moral distress.
And moral distress is when you
know what you should do.
According to your morals, you
can't do it, because you're not
the decision maker. So human
nurses experience this hugely.
And there's been a really good
bunch of research done looking
at mental health impacts of
that. Now, I would argue that
pretty much everyone in the
veterinary team is in that
situation, nurses even more so
because you're not necessarily
the decision maker. And you're
often doing things that you may
not agree with. But vets are to
because of property law, because
of ownership, we don't always
get to make decisions, owners
are the legal ones who can make
a decision and we can't legally
overrule them. And if you take
that a step further, this is
getting quite intense. But we
can be the instruments of harm
or what we consider to be harms.
And when our guiding principle
or our ethics is telling us
we're here to help an animal and
then we are what we might
consider hurting it. That can be
incredibly destructive to us.
The concept of ethics rounds in
vet practices can actually help
vets in practice, especially
with this moral distress.
Hindsight is a wonderful thing.
Yeah, and being able to sit down
in a structured way to talk
through not the clinical aspects
of the case, because we can all
go on about that forever. It's
the ethical aspects of the case.
It's how it made us feel okay,
and what we thought about it,
and being able to openly talk
about that with colleagues is
hugely important. We all have
these cases, we need to be able
to talk about these with
colleagues, I grant you, it's
more difficult when you're not
in a practice with them. But
that tells me then that within
that framework of doing these
kind of home euthanasias, that's
a framework that we need to set
that up then, there needs to be
a way to open the dialogue. But
within practice, I think it
could be hugely beneficial to
discuss these cases after the
fact. And I know that you found
this in shelter care, when we
went too far with a case.
Everyone gets attached, and you
just end up doing too much.
Those are really good cases to
discuss, to sit around and talk
about after the fact and learn
from them. So you can make those
decisions as you talked about
beforehand, before you go down
that road.
Nathalie Dowgray: Yeah, it's a
lot easier to have those
decision making tools in place
before there's an animal in
front of you.
If you want to hear more from
Karen, ISFM veterinary members
can access her lectures and our
virtual Congress from 2022, and
also 2023, in the event section
of our portal. And now we're
going over to Kelly St Denis
who's talking with Dr. Alison
Diesel on her JFMS clinical
spotlight article, the feline
skin microbiome,
interrelationship between health
and disease. Don't forget that
JFMS is an open access journal
now and the link to read the
full article is in the show
notes.
Alison Diesel: There's nothing
out there on allergies and cats.
That's exactly why I want to do
something like that.
Kelly St Denis: And are you
finding, just out of curiosity,
if you're starting to see more
cats coming to secondary
referral practice than you used
to?
Alison Diesel: Yeah, for sure.
Definitely does seem that owners
are bringing their cats in as
well, recognising the fact that
there is skin disease in cats.
And so it's nice to actually see
this species starting to come
into the clinics a bit more too.
One of the biggest frustrations
right in feline dermatology is
that everything really looks the
same and you sit there and it's
like am I dealing with fleas or
am I dealing with something
other than fleas. Is it
allergies? It is non allergy?
Working with that is just a lot
of fun.
Kelly St Denis: Yeah, that's
really good. I'm starting to see
more skin cases in my practice,
too. So it's been interesting
learning about all of this
stuff. I think back when I was
in vet college and reading the
article, traditionally, our
understanding of the
microorganisms that live on the
feline skin have been related to
culture, live organisms that can
successfully be cultured. The
article will discuss this more
advanced technique, so the next
generation sequencing. So I
wondered if you could tell us a
little bit more about that and
what the benefits are compared
to what we've used in the past.
Alison Diesel: So the benefits
of the next generation
sequencing is that it really
does give us a hugely clear
picture about what actually is
living on our skin, as opposed
to being limited to things that
will grow out on a culture
plate, the next generation
sequencing really picks up on
everything on the DNA level. So
it's basically able to detect
all the different organisms, not
just ones that are going out, as
opposed to the historical
studies, that you'd maybe pick
up a handful of organisms that
are part of whatever disease
process or just the quote,
unquote, normal skin flora of
dogs, cats, people, etc. The
next generation sequencing
really takes it a huge step
further, where it's identifying,
like at times hundreds and 1000s
of organisms from between
bacteria, fungal organisms,
viruses, that are all part of
the normal cutaneous microbiome.
So we're just learning a lot
more, and finding the massive
diversity of these organisms
that really live on the skin.
Kelly St Denis: Yeah, it's
almost mind boggling. And then
on top of that, in the article,
you talk about the microbiome,
but also the metabolome. That's
another aspect of it, because
it's not just about the
microbiome is it, you're trying
to look at other things.
Alison Diesel: Yes, exactly.
Right now, the next generation
sequencing really focuses
primarily on what are the
organisms that are there. These
newer studies coming out are
even looking at it from the
standpoint of okay, what are the
organisms? But then also, what
are they producing? What are
their metabolites? What are the
proteins that are there as well?
Because it's not just about the
bugs, it's about the, what are
they doing? And how are they
interacting with the cutaneous
environment. And I think the
impact on grooming in this
species is might be at least a
big reason for why we're seeing
some of those differences,
especially if we're talking
about states of health and
disease. If we're seeing a shift
in the microbiome, how does that
relate to the grooming practices
of the cat? Are we seeing it
because they're, as an example,
an itchy cat? And so we're
seeing a lot more grooming where
they're now translating the
normal microbiome into something
else? Are we seeing more oral
cavity Flora coming in? That's
taking over the cutaneous aspect
of things, and or vice verse, is
the cutaneous microbiome now
infiltrating the oral cavity and
the GI tract, I think we're
gonna see a lot of interrelated
conditions here. And already in
human medicine, they talk about
the impact of the gut microbiome
on the health of the skin, I
think, especially if you're
talking about a species where
grooming is part of their just
normal behaviour, the changes
and the impacts that we might
see as part of that, and in
different states of health and
diseases is, I think, going to
be really interesting.
Kelly St Denis: Reflecting off
the GI stuff that we know, what
is your sense about how
antibiotics are going to be
possibly negatively impacting
the skin microbiome? And how to
practitioners balance that with,
well, I think the cat might have
a bacterial pyoderma, which is
more difficult to diagnose in a
cat than a dog.
Alison Diesel: I think that's
one of those things where it's
weighing the risk versus the
benefit. And if we're
benefiting, or is it you're
treating an active infection? I
think we're going to have to
take that into a well, the cat
needs antibiotics at this time,
but now downstream to your point
of how long does it take to get
back. And not only the
microbiome standpoint, but the
metabolism part of things. So
that's something that in talking
with the folks that are doing
the GI research that can be
impacted for an extended period
of time, I think this is an area
that warrants a lot of
consideration. This is an area
that especially from the ability
to use, I guess more biological
agents, as opposed to just
straight up antibiotics as an
example. So things that might
not necessarily fully negative
impact overall, but might help
to take out the more problematic
pathogenic organisms that we're
looking at it, can we do better
at targeting our therapeutics
from either a topical standpoint
or a going into the whole realm
of prebiotic/probiotic
standpoint? And is that
something that we can tap into
as far as being able to build a
bit more balance? Yeah.
Nathalie Dowgray: Thank you for
listening. If you're an ISFM
member, please don't forget you
can access the full version of
the podcast and all the other
ISFM member benefits including
congress recordings, monthly
webinars and our clinical club
as well as the discussion forum
and much much more at
portal.icatcare.org. Virtual
Access for Members to our 2023
Dublin Congress has also just
gone live. So don't forget to
start catching up on that. If
you're looking for more CPD in
August, we also have our
quarterly Cat Friendly Clinic
webinar, that's going to be
going live on the 15th. Please
do join ISFM’s own Laura Watson,
and she's going to be talking
about a cat friendly home,
helping the caregivers get it
right. Keep an eye out on ISFM's
social media for more details
about how to join. We'll be back
again next month. If you don't
want to miss out please make
sure you've signed up to
Chattering With ISFM on your
favourite podcast platform.